Company: LRHC
Filing Date: 2025-09-19
Form Type: PRE 14C
Source: 0001213900-25-089617
Chunk: 7

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-19
Form: PRE 14C
Chunk 7
---
 foregoing, if the Company is able to obtain the
written consent of holders of a majority of the shares of its issued and outstanding shares of Common Stock to obtain Stockholder Approval
(the “Stockholder Consent”), the Company may satisfy the foregoing obligations under the Facility Agreement by obtaining such
consent and submitting for filing with the SEC a preliminary information statement on Schedule 14C no later than 20 days prior to the
Stockholder Meeting Deadline, followed by a definitive information statement on Schedule 14C no later than the timeline for such filing
prescribed by the Exchange Act; provided, however, that if the Company receives a notification from the Nasdaq Capital Market that the
Stockholder Consent must be modified, then the Company shall use its best efforts to provide a new Stockholder Consent.

In satisfaction of the latter
contractual obligation, on September 19, 2025, the Majority Stockholders, holding approximately 95.65% of the votes of our outstanding
voting stock as of the Record Date, provided the Stockholder Approval under the signed Majority Stockholders Consent. The Majority Stockholders
Consent provides the affirmative Stockholder Approval required under the Amended Facility Agreement for issuance of all shares of Common
Stock issuance under the Amended Facility Agreement, including, but not limited to the issuance of the shares of Common Stock in excess
of 19.99% of the Company’s issued and outstanding Common Stock at a price less than the minimum price required by the Nasdaq Capital
Market, in compliance with the rules and regulations of the Nasdaq Capital Market.

<div align='center'>3</div>

In addition, the issuance
of shares of Common Stock pursuant to the Facility in excess of 19.99% of the Company’s issued and outstanding Common Stock implicates
Nasdaq’s 20% Rule described below requiring prior stockholder approval in order to maintain our listing on Nasdaq. The Company is
currently listed on the Nasdaq Capital Market and is subject to the Nasdaq’s listing rules.

This Information Statement
contains a brief summary of the material terms of the Amended Facility Agreement and Amended RRA approved by the Board of Directors and
the Majority Stockholders. We encourage you to read the Amended Facility Agreement and the Amended RRA, which were previously filed as
Exhibits 10.1 and 10.2, respectively, to the Company’s Current Report on Form 8-K filed with the SEC on September 19, 2025.

The Am